At the time of writing, Bionano Genomics Inc [BNGO] stock is trading at $1.67, up 5.70%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BNGO shares have gain 7.74% over the last week, with a monthly amount glided 4.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bionano Genomics Inc [NASDAQ: BNGO] stock has seen the most recent analyst activity on November 15, 2024, when Ladenburg Thalmann downgraded its rating to a Neutral. Previously, BTIG Research downgraded its rating to Neutral on September 10, 2024. On January 05, 2023, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $4 on the stock. BTIG Research started tracking with a Buy rating for this stock on June 16, 2021, and assigned it a price target of $10. In a note dated September 24, 2020, Ladenburg Thalmann initiated a Buy rating and provided a target price of $1.25 on this stock.
For the past year, the stock price of Bionano Genomics Inc fluctuated between $1.41 and $11.40. Currently, Wall Street analysts expect the stock to reach $46.5 within the next 12 months. Bionano Genomics Inc [NASDAQ: BNGO] shares were valued at $1.67 at the most recent close of the market. An investor can expect a potential return of 2684.43% based on the average BNGO price forecast.
Analyzing the BNGO fundamentals
According to Bionano Genomics Inc [NASDAQ:BNGO], the company’s sales were 28.72M for trailing twelve months, which represents an 21.31% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -1.28%, Pretax Profit Margin comes in at -1.34%, and Net Profit Margin reading is -1.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.86 and Total Capital is -0.66. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Bionano Genomics Inc [NASDAQ:BNGO] has a current ratio of 2.12. Further, the Quick Ratio stands at 1.82, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 0.59, the price to book ratio is 0.33.
